FFCP PHASE1:Hg19::chr18:59518131..59518142,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr18:59518131..59518142,- | |||
|coexpression_cluster_id=C169 | |||
|description=CAGE_peak_at_chr18:59518131..59518142,- | |||
|id=chr18:59518131..59518142,- | |||
|ontology_enrichment_celltype=CL:0000764!6.54e-20!2;CL:0000765!6.54e-20!2;CL:0000050!6.54e-20!2;CL:0000038!6.54e-20!2;CL:0000558!6.54e-20!2;CL:0000547!6.54e-20!2;CL:0000549!6.54e-20!2;CL:0000550!6.54e-20!2;CL:0000552!6.54e-20!2;CL:0000167!2.79e-11!1;CL:0000164!2.79e-11!1;CL:0000502!2.79e-11!1;CL:0000172!2.79e-11!1;CL:0000173!2.79e-11!1;CL:0002351!2.79e-11!1;CL:0002553!4.15e-11!1 | |||
|ontology_enrichment_celltype_v019=CL:0000167;3.10e-50;1!CL:0000164;3.10e-50;1!CL:0000502;3.10e-50;1!CL:0000172;3.10e-50;1!CL:0000173;3.10e-50;1!CL:0000150;8.14e-07;9!CL:0000163;8.14e-07;9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000167,2.42e-50,1;CL:0000164,2.42e-50,1;CL:0000502,2.42e-50,1;CL:0000172,2.42e-50,1;CL:0000173,2.42e-50,1;CL:0002351,2.42e-50,1;CL:0000150,7.91e-07,9;CL:0000163,7.91e-07,9 | |||
|ontology_enrichment_development_v019=CL:0002351;3.10e-50;1 | |||
|ontology_enrichment_disease=DOID:2355!2.53e-11!1;DOID:4430!2.79e-11!1 | |||
|ontology_enrichment_disease_v019=DOID:2355;1.46e-50;1!DOID:4430;3.10e-50;1!DOID:74;4.32e-26;2!DOID:1287;8.82e-14;4!DOID:169;1.38e-09;6 | |||
|ontology_enrichment_disease_v019_2=DOID:2355,1.46e-50,1;DOID:4430,2.42e-50,1;DOID:74,4.32e-26,2;DOID:1287,8.82e-14,4;DOID:169,1.32e-09,6 | |||
|ontology_enrichment_uberon=UBERON:0002106!7.42e-14!3;UBERON:0004854!7.42e-14!3;UBERON:0009034!7.42e-14!3;UBERON:0002095!7.42e-14!3;UBERON:0004782!7.42e-14!3;UBERON:0003281!7.42e-14!3;UBERON:0009664!7.42e-14!3;UBERON:0002296!7.42e-14!3;UBERON:0005602!7.42e-14!3;UBERON:0001179!7.42e-14!3;UBERON:0006293!7.42e-14!3;UBERON:0000945!1.80e-11!8;UBERON:0010039!1.80e-11!8;UBERON:0000998!7.46e-11!1;UBERON:0006868!7.46e-11!1 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.24406205754817,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.120859449591622,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.219259876645935,0.522870902049801,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.507447609232169,0,0,0.238231775457789,0,0,0.540031437238115,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.150323419414493,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.225980740780532,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.58843991634178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.32506888912221,0,0.13223260174269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122026264901963,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.80057074828547,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.423387050190929,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.82190377816914,0,2.82811856521951,0,0,0,0,0,0.45120521581504,0.89947040332436,0,0,0,0.730336388246517,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213233981900981,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr18:59518131..59518142,- | |||
}} |
Latest revision as of 01:44, 26 July 2015
Short description: | p@chr18:59518131..59518142, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr18:59518131..59518142, - |
Coexpression cluster: | C169_hereditary_adult_gall_lymphangiectasia_chronic_b_choriocarcinoma |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
peptide hormone secreting cell | 2.42e-50 | 1 |
enteroendocrine cell | 2.42e-50 | 1 |
type D enteroendocrine cell | 2.42e-50 | 1 |
somatostatin secreting cell | 2.42e-50 | 1 |
pancreatic D cell | 2.42e-50 | 1 |
progenitor cell of endocrine pancreas | 2.42e-50 | 1 |
glandular epithelial cell | 7.91e-07 | 9 |
endocrine cell | 7.91e-07 | 9 |
Ontology term | p-value | n |
---|---|---|
anemia | 1.46e-50 | 1 |
somatostatinoma | 2.42e-50 | 1 |
hematopoietic system disease | 4.32e-26 | 2 |
cardiovascular system disease | 8.82e-14 | 4 |
neuroendocrine tumor | 1.32e-09 | 6 |